Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Huntington's disease (HD) is a rare, inherited neurodegenerative disorder.
• It is caused by a CAG trinucleotide repeat expansion in the Huntingtin (HTT) gene.
• Mutant HTT (mHTT) protein accumulation leads to progressive brain cell degeneration, particularly in the striatum.

Purpose of the Study:

• To review the normal function of wild-type HTT (wtHTT) and the pathological mechanisms of mHTT.
• To elucidate how mHTT disrupts medium spiny neuron (MSN) function, epigenetic modifications, and transcriptional pathways.
• To explore non-cell autonomous pathways contributing to MSN damage in HD.
• To provide an overview of current and potential therapeutic strategies for HD.

Main Methods:

• Literature review of existing research on Huntington's disease.
• Analysis of the molecular and cellular mechanisms underlying HD pathogenesis.
• Discussion of genetic, epigenetic, and cellular pathways involved in neuronal dysfunction.
• Synthesis of information on therapeutic approaches for HD.

Main Results:

• mHTT protein disrupts normal wtHTT functions, leading to MSN dysfunction and death.
• mHTT influences epigenetic regulation and transcriptional activity within neurons.
• Non-cell autonomous mechanisms exacerbate neuronal damage in the HD brain.
• A comprehensive understanding of these mechanisms is crucial for therapeutic development.

Conclusions:

• The neuropathology of HD involves complex interactions between mHTT, neuronal function, epigenetic changes, and intercellular communication.
• Targeting these specific mechanisms offers potential for novel therapeutic interventions.
• Further research into HD pathogenesis is essential for improving treatment outcomes and slowing disease progression.